Targeting Mitochondria 2017 at a glance
Among Speakers and Topics already confirmed:
Part 1: Targeting Mitochondria 2017: Recent Advances on Mitochondrial Dysfunctions in Chronic Diseases: The Mechanistic
Targeting mitochondria by small RNAs: update and prospects
Ivan Tarassov, University of Strasbourg, France
Hydrogen sulfide and mitochondrial function
Csaba Szabo,University of Texas, USA
Mitochondrial ROS mediated signaling pathways: activation and regulation upon inflammation
Andrey Kozlov, L. Boltzmann Institute für experimentelle und klinische Traumatologie, Austria
Ana Lechuga-Vieco, Fundación Centro Nacional de Investigaciones Cardiovasculares, Spain
Shey-Shing Sheu, Thomas Jefferson University, USA
Vladimir Gogvadze, Karolinska Institute, Sweden
Probing Mitochondrial Chemical Biology with Organelle-Specific Peptides
Shana O'Kelley, University of Toronto, Canada
Marten Szibor, University of Helsinki, Finland
High-content mitochondrial analysis by live-cell microscopy
Werner Koopman, Radboudumc University, The Netherlands
Part 3: Strategies to target Mitochondria: Recent Clinical & Potential Therapeutic Studies
Mitochondria-targeted rechargeable antioxidants as pharmaceuticals inhibiting the aging program in humans
Maxim Skulachev, Moscow State University, Russia
The impact of mitochondria-targeted antioxidants on cancer progression
Martin Bergö, Sahlgrenska Cancer Center, Sweden
Prevention of mitochondrial disease transmission
Yuko Takeda, The Newcastle University, United Kingdom
Polymeric nanoparticle-based mitochondria-targeting systems
Han Chang Kang, The Catholic University of Korea, The Republic of Korea
mtDNA induced inflammatory response in lungs: recent scientific advances
Bartosz Szczesny, University of Texas Medical Branch at Galveston, USA
iPSC-based drug discovery for neurological mitochondrial disease
Alessandro Prigione, Max Delbrueck Center for Molecular Medicine, Germany
Quantifying mitochondrial uptake of nucleobase derivatives through click chemistry
Kurt Hoogewijs, The Wellcome Trust Centre for Mitochondrial Research, Newcastle University, United Kingdom
Human mitochondrial leucyl tRNA synthetase can suppress non cognate pathogenic mt-tRNA mutations
Hue-Tran Hornig-Do, University of Cologne, Germany
| Day 1 - October 23, 2017 | |
| 07h30 - 9h00 | Registration & Welcoming |
| 08h55 | Welcome Address |
| 09h00 - 11h00 | Targeting Mitochondria 2017: Recent Advances on Mitochondrial Dysfunctions in Chronic Diseases: The Mechanistic (Part I) |
| 11h00 - 11h30 | Coffee Break & Poster Session |
| 11h30 - 12h30 | Short Oral Presentations |
| 12h30 - 14h00 | Lunch Break & Poster Session |
| 14h00 - 16h00 | How to Evaluate Mitochondria Function/Dysfunction? |
| 16h00 - 16h30 | Coffee Break & Poster Session |
| 16h30 - 17h30 | Short Oral Presentations |
| 17h30 | End of the first day |
| 20h00 |
Targeting Mitochondria Dinner To participate, please register online before October 9 |
| Day 2 - October 24, 2017 | |
| 08h55 | Opening of the second day |
| 09h00 - 10h30 |
Strategies to target Mitochondria: Recent Clinical & Potential Therapeutic Studies (Part I) |
| 10h30 - 11h00 | Coffee Break & Poster Session |
| 11h00 - 12h30 | Strategies to target Mitochondria: Recent Clinical & Potential Therapeutic Studies (Part II) |
| 12h30 - 14h00 | Lunch Break & Poster Session |
| 14h00 - 15h30 | Short Oral Presentations (Part I) |
| 15h30 - 16h15 | Coffee Break & Poster Session |
| 16h15 - 17h00 | Short Oral Presentations (Part II) |
| 17h15 - 18h00 |
Conclusion of Targeting Mitochondria 2017 Targeting Mitochondria Awards |
| 18h00 | End of tTargeting Mitochondria 2017 |
